Why are people turning to compounded GLP-1 medications right now?

Recent shortages and high demand for brand-name GLP-1 medications like Ozempic®, Wegovy®, Mounjaro®, and Zepbound® have made it harder for some patients to access treatment. As a result, compounding pharmacies have started offering versions of semaglutide and tirzepatide—but these alternatives aren’t identical to FDA-approved products and may carry safety risks.